Have You Been Diagnosed
with Mitral Regurgitation?

You may be eligible for a clinical trial that includes
a minimally-invasive option for mitral valve repair.

Learn More

A Clinical Trial That Includes A Minimally-Invasive
Treatment Option For Mitral Regurgitation Patients

The purpose of the REPAIR MR Clinical Trial is to study the safety and effectiveness of a Transcatheter Mitral Valve Repair (TMVr) procedure for patients with mitral regurgitation who are at moderate risk for surgical therapy. TMVr is a minimally-invasive procedure that does not require an incision to the patient’s chest or the use of the heart-lung machine.

Watch this educational video to learn about the REPAIR MR Clinical Trial that will evaluate the Abbott MitraClip™ Transcatheter Mitral Valve Repair System for mitral regurgitation patients.

What Is Transcatheter Mitral Valve Repair (TMVr)?

Transcatheter Mitral Valve Repair (TMVr) is a minimally-invasive treatment option for patients with mitral regurgitation. During TMVr, a MitraClip™ implant is inserted through a vein into the heart. The MitraClip™ implant grasps the defective mitral valve leaflets, closes the center of the mitral valve, and reduces mitral regurgitation. TMVr is performed without an incision to the patient’s chest and the patient does not need to be on a heart-lung machine. TMVr is proven to be safe with experience of over 100,000 implants worldwide.

Watch this video to see how a MitraClip™ implant is positioned in the heart.

Important facts about TMVr include:

  • TMVr is a less-invasive procedure than surgical mitral valve repair.
  • TMVr uses catheters to access and repair the mitral valve.
  • TMVr does not require the patient to be on a heart-lung machine.
  • TMVr is only performed by doctors who have extensive and specialized training.

Who Can Participate In
The REPAIR MR Clinical Trial?

Doctors and research teams that specialize in mitral valve therapy can determine if you are eligible to participate in the REPAIR MR Clinical Trial for mitral regurgitation patients. You may qualify if:

You have been diagnosed with mitral regurgitation

You are 18 years of age or older

You are not pregnant or thinking about getting pregnant

Find Out If You Qualify for REPAIR MR

Approximately 500 patients will participate in the REPAIR MR Clinical Trial at 60 medical centers across the United States, Canada and Europe. A team of medical experts who specialize in mitral valve therapy will monitor all patients who enroll in the REPAIR MR Clinical Trial.

For more information about the REPAIR MR Clinical Trial and a full list of clinical sites, visit ClinicalTrials.gov.

Learn More At
ClinicalTrials.gov

Download Free Brochure To Learn More

To learn more about mitral regurgitation (symptoms, causes and risks), treatment options, and the REPAIR MR Clinical Trial, please download our free brochure.

Download Free Patient Brochure